Riva Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $3M
Investors
- 2
About Riva Therapeutics
Based in California, US, and co-founded by Brion W. Murray (President and CSO), William C. Hahn, Andrew Aguirre, and Francisca Vazque in 2022, Riva Therapeutics operates as a biotechnology company developing transformative medicines for cancer patients. The company specializes in precision oncology and leverages deep knowledge of genomic dependencies to create a new generation of small molecule therapeutics that selectively target essential tumor cell processes beyond DNA damage repair. Riva’s precision lethal therapies aim to provide profound clinical activity, be well-tolerated, and substantially improve patient lives.
Who invested in Riva Therapeutics
2 investors across 1 round
See all investors in Riva Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 22, 2023
Amount
$3M
Investors
Questions about Riva Therapeutics
Who invested in Riva Therapeutics?
Riva Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Riva Therapeutics raised?
Riva Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Riva Therapeutics last raise money?
Riva Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does Riva Therapeutics do?
Based in California, US, and co-founded by Brion W.
Where is Riva Therapeutics headquartered?
Riva Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Riva Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Riva Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Riva Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.